The All India Institute Of Medical Sciences (AIIMS) has invited applications for volunteers, who want to take part in the COVAXIN Phase-3 trial, which was indigenously developed by Bharat Biotech. The institute on Thursday released an advertisement regarding the enrolment of volunteers. COVAXIN is a whole-virion inactivated vaccine co-sponsored by ICMR and Bharat Biotech.from IndiaTV India: Google News Feed https://ift.tt/2M6pc9R
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.